4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone has been researched along with Keratosis, Oral in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, YP; Johnson, GK; Squier, CA | 1 |
Akerkar, SA; Borukhova, A; Carmella, SG; Gopalakrishnan, R; Harris, RE; Hecht, SS; Kresty, LA; Stoner, GD | 1 |
2 other study(ies) available for 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and Keratosis, Oral
Article | Year |
---|---|
Effects of nicotine and tobacco-specific nitrosamines on hamster cheek pouch and gastric mucosa.
Topics: Animals; Carcinogens; Cheek; Cricetinae; Drug Synergism; Epithelium; Gastric Mucosa; Hyperplasia; Keratosis; Leukoplakia, Oral; Male; Mesocricetus; Mouth Mucosa; Nicotine; Nitrosamines; Papilloma; Plants, Toxic; Tobacco, Smokeless | 1994 |
Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia.
Topics: Adult; Analysis of Variance; Biomarkers; Carcinogens; Confidence Intervals; Humans; Incidence; Leukoplakia, Oral; Male; Nitrosamines; Odds Ratio; Plants, Toxic; Sensitivity and Specificity; Tobacco, Smokeless | 1996 |